227 related articles for article (PubMed ID: 15233214)
21. Preoperative somatostatin analogs treatment in acromegalic patients with macroadenomas. A meta-analysis.
Zhang L; Wu X; Yan Y; Qian J; Lu Y; Luo C
Brain Dev; 2015 Feb; 37(2):181-90. PubMed ID: 24815226
[TBL] [Abstract][Full Text] [Related]
22. Surgical-pharmacological interactions in the treatment of acromegaly.
Abreu C; Guinto G; Mercado M
Expert Rev Endocrinol Metab; 2019 Jan; 14(1):35-42. PubMed ID: 30595057
[TBL] [Abstract][Full Text] [Related]
23. Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates.
Losa M; Mortini P; Urbaz L; Ribotto P; Castrignanó T; Giovanelli M
J Neurosurg; 2006 Jun; 104(6):899-906. PubMed ID: 16776333
[TBL] [Abstract][Full Text] [Related]
24. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
Pivonello R; Ferone D; Filippella M; Faggiano A; De Martino MC; Auriemma RS; Rota F; Lombardi G; Colao A
J Endocrinol Invest; 2003; 26(8 Suppl):82-8. PubMed ID: 15233220
[No Abstract] [Full Text] [Related]
25. [Treatment of acromegaly in Aarhus University Hospital. A retrospective investigation of the period from 1994 to 2004].
Madsen M; Matthiesen EB; Poulsen PL; Weeke J; Astrup J; Jørgensen JO
Ugeskr Laeger; 2007 Mar; 169(10):907-10. PubMed ID: 17359734
[TBL] [Abstract][Full Text] [Related]
26. Can treatment with somatostatin analogs replace neurosurgery?
Lorenzo-Solar M; Castro A; Peino R; Fernandez-Alvarez J; Dieguez C; Casanueva FF
J Endocrinol Invest; 2005; 28(11 Suppl International):48-52. PubMed ID: 16625845
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
[TBL] [Abstract][Full Text] [Related]
29. Primary medical therapy for acromegaly.
Sheppard MC
Clin Endocrinol (Oxf); 2003 Apr; 58(4):387-99. PubMed ID: 12641619
[TBL] [Abstract][Full Text] [Related]
30. [Value and results of trans-sphenoid surgery of the hypophysis in acromegaly].
Knappe G
Z Arztl Fortbild (Jena); 1992 Oct; 86(20):1013-7. PubMed ID: 1441638
[No Abstract] [Full Text] [Related]
31. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
32. Genetic abnormalities of somatostatin receptors in pituitary tumors.
Lania A; Mantovani G; Spada A
Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
[TBL] [Abstract][Full Text] [Related]
33. Surgery for acromegaly.
Scott RM
J Neurosurg; 1999 Apr; 90(4):809. PubMed ID: 10193637
[No Abstract] [Full Text] [Related]
34. Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.
Ben-Shlomo A; Melmed S
J Clin Endocrinol Metab; 2003 Mar; 88(3):963-8. PubMed ID: 12629068
[No Abstract] [Full Text] [Related]
35. Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas.
Colao A; Filippella M; Di Somma C; Manzi S; Rota F; Pivonello R; Gaccione M; De Rosa M; Lombardi G
Endocrine; 2003 Apr; 20(3):279-83. PubMed ID: 12721508
[TBL] [Abstract][Full Text] [Related]
36. New medical therapies of acromegaly.
Maffezzoni F; Frara S; Doga M; Mazziotti G; Giustina A
Growth Horm IGF Res; 2016; 30-31():58-63. PubMed ID: 27745780
[TBL] [Abstract][Full Text] [Related]
37. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection.
Mozas J; Ocón E; López de la Torre M; Suárez AM; Miranda JA; Herruzo AJ
Int J Gynaecol Obstet; 1999 Apr; 65(1):71-3. PubMed ID: 10390105
[TBL] [Abstract][Full Text] [Related]
38. Evidence for dopamine agonists in the treatment of acromegaly.
Jaquet P
J Endocrinol; 1997 Oct; 155 Suppl 1():S59-60. PubMed ID: 9389998
[No Abstract] [Full Text] [Related]
39. Proliferation activity in somatotroph pituitary adenomas.
Delgrange E; Donckier J
Mayo Clin Proc; 1998 Oct; 73(10):1027-8. PubMed ID: 9787756
[No Abstract] [Full Text] [Related]
40. Acute liver injury and octreotide.
González-Martín JA; Donnay S; Morillas J; Gómez-Aparicio C; Garcia-Cano J; Pérez-Vigara G; Roldán A
Am J Gastroenterol; 1996 Nov; 91(11):2434-5. PubMed ID: 8931436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
